Max Ragusi

Research Staff Other

Strategic program(s):

Contact

mragusi2@umcutrecht.nl

Pure profile

Recent publications

All publications

Automated volumetric iRECIST-inspired CT assessment of treatment response to dual immune checkpoint inhibition in metastatic renal cell carcinoma R C J Kraaijveld, B Ma, B B M Suelmann, F J Wessels, M A A Ragusi, B de Keizer, K G A Gilhuijs
European Journal of Radiology, 2026, vol. 203

Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI Max A.A. Ragusi, Bas H.M. van der Velden, Carla Meeuwis, Eric Tetteroo, Emile G. Coerkamp, Thiemo J.A. van Nijnatten, Frits H. Jansen, Elian J.M. Wolters-Van Der Ben, Lisa Jongen, Fleur van Raamt, Monique D. Dorrius, Janneke Verloop, Max A. Viergever, Ruud M. Pijnappel, Sjoerd G. Elias, Kenneth G.A. Gilhuijs
Radiology, 2023, vol. 307, p.1-8

Personalizing endocrine therapy for breast cancer using MRI Max Ragusi
2022

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA M.A.A. Ragusi, B.H.M. van der Velden, M.C. van Maaren, E. van der Wall, C. H. van Gils, R. M. Pijnappel, K.G.A. Gilhuijs, S.G. Elias
Breast Cancer Research and Treatment, 2022, vol. 193, p.161-173

Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancer Max Aa Ragusi, Gonneke Ao Winter-Warnars, Jelle Wesseling, Sabine C. Linn, Regina G. Beets-Tan, Bas Hm van der Velden, Sjoerd G. Elias, Kenneth Ga Gilhuijs, Claudette E. Loo
The British journal of radiology, 2021, vol. 94, p.1-10

Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients Max A A Ragusi, Tycho Bismeijer, Bas H M van der Velden, Claudette E Loo, Sander Canisius, Jelle Wesseling, Lodewyk F A Wessels, Sjoerd G Elias, Kenneth G A Gilhuijs
The Breast, 2021, vol. 60, p.230-237